glp-1 weight loss guidelines Researchers find medications safe to continue before surgery in patients with diabetes and obesity GLP-1 Therapy Part 1: Setting
Description
Theres a more positive outlook on life
Supplementary Information Additional file 1 (download DOCX : Figure S1
For patients experiencing significant adverse effects, dose adjustments or alternative therapies may be necessary
Outcomes Obstetric outcomes were pre-eclampsia, GDM, gestational age (days), birth weight (grams), placental weight (grams), stillbirth, placental abruption, and placenta previa
Safranal : May influence neurotransmitter pathways, including serotonin, which plays a role in appetite and mood regulation
